ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 131 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,394,315 | -64.6% | 93,711 | -60.3% | 0.00% | -100.0% |
| Q2 2023 | $6,771,750 | -71.7% | 236,114 | -76.4% | 0.00% | -50.0% |
| Q1 2023 | $23,934,116 | +105.7% | 998,503 | +45.6% | 0.00% | +100.0% |
| Q4 2022 | $11,633,780 | +627.1% | 685,954 | +535.2% | 0.00% | – |
| Q3 2022 | $1,600,000 | +453.6% | 107,986 | +488.1% | 0.00% | – |
| Q2 2022 | $289,000 | -81.2% | 18,363 | -67.8% | 0.00% | – |
| Q1 2022 | $1,536,000 | -67.5% | 56,972 | -55.4% | 0.00% | – |
| Q4 2021 | $4,724,000 | +467.1% | 127,625 | +632.2% | 0.00% | – |
| Q3 2021 | $833,000 | +59.0% | 17,430 | +12.6% | 0.00% | – |
| Q2 2021 | $524,000 | +4.0% | 15,474 | +26.6% | 0.00% | – |
| Q1 2021 | $504,000 | +68.0% | 12,226 | +76.8% | 0.00% | – |
| Q4 2020 | $300,000 | -45.4% | 6,915 | -46.1% | 0.00% | – |
| Q3 2020 | $549,000 | +19.9% | 12,820 | +30.6% | 0.00% | – |
| Q2 2020 | $458,000 | +125.6% | 9,817 | -34.4% | 0.00% | – |
| Q1 2020 | $203,000 | – | 14,970 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |